Christopher Gibson

Dr. Christopher Gibson is a Co-Founder of Recursion Pharmaceuticals, where he serves as Chief Executive Officer and Board Member. He completed his PhD in Bioengineering at the University of Utah in the fall of 2013 before taking a leave of absence from medical school (he was enrolled in the MD/PhD program) to found and grow Recursion. He developed the core technology underlying this venture while in the lab of Dean Li. Chris comes from a family of entrepreneurs, is a graduate of Rice University with degrees in bioengineering and managerial studies, and recently completed an intense course in entrepreneurship at Stanford GSB. Chris is also a Board Member of CureHHT, a patient advocacy group for Hereditary Hemorrhagic Telangiectasia.